Hologic, Inc. Stock
Stocks
HOLX
US4364401012
Advanced Medical Equipment & Technology
|
Delayed
Nasdaq
23:00:00 06/04/2026 +03
|
5-day change | 1st Jan Change | ||
| 76.01 USD | +0.48% |
|
-.--% | +2.04% |
| 07-30 | Quest Diagnostics And Hologic, Inc. Conduct National Health Trends Study On Bacterial Vaginosis And STI Co-Infection | CI |
| 06-30 | Hologic Recalls BioZorb Implantable Markers, FDA Says | MT |
| Market Cap | 16.97B 14.53B 13.6B 12.44B 23.4B 1,624B 23.67B 161B 62.56B 815B 63.71B 62.32B 2,696B | P/E 2024 |
24.3x | P/E 2025 | 27x |
|---|---|---|---|---|---|
| Enterprise Value | 17.39B 14.89B 13.93B 12.75B 23.98B 1,664B 24.26B 165B 64.11B 835B 65.29B 63.87B 2,763B | EV / Sales 2024 |
4.74x | EV / Sales 2025 | 3.75x |
| Free-Float |
73.08% | Yield 2024 * |
-
| Yield 2025 | - |
Last Transcript: Hologic, Inc.
| 1 day | +0.48% | ||
| 6 months | +0.77% | ||
| Current year | +2.04% |
| Current year | 74.49 |  | 76.07 |
| 1 year | 63.19 | | 76.07 |
| 3 years | 51.9 | | 84.67 |
| 5 years | 51.9 | | 87.88 |
| 10 years | 26.49 | | 87.88 |
| Manager | Title | Age | Since |
|---|---|---|---|
Joe Almeida
CEO | Chief Executive Officer | 63 | 07/04/2026 |
Brian Montgomery
DFI | Director of Finance/CFO | - | 16/04/2026 |
Essex Mitchell
COO | Chief Operating Officer | 46 | 01/01/2024 |
| Director | Title | Age | Since |
|---|---|---|---|
Joe Almeida
BRD | Director/Board Member | 63 | 07/04/2026 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 4/7/26 A | Issuer sale | Director | 23,407 | 0.0105% | ||
| 2/27/26 A | Tax | General Counsel | 185 | 0.0001% | ||
| 2/26/26 A | Free | Director | 3,190 | 0.0014% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.48% | -.--% | +11.35% | -1.11% | 16.97B | |
| +0.27% | +6.97% | +25.86% | +19.39% | 233B | |
| +1.36% | +8.10% | +3.33% | -12.35% | 154B | |
| +1.16% | -3.98% | -20.44% | +31.92% | 134B | |
| +2.03% | -2.82% | -52.56% | -0.08% | 73B | |
| +0.98% | +2.26% | -16.22% | -12.49% | 52.24B | |
| -0.04% | -1.98% | +9.73% | +18.19% | 51.75B | |
| +1.73% | +7.05% | +30.72% | +35.16% | 44.91B | |
| +1.49% | -0.36% | +35.91% | +53.26% | 40.35B | |
| +1.03% | +1.53% | -0.53% | +8.54% | 33.8B | |
| Average | +1.05% | +1.64% | +2.71% | +14.04% | 83.34B | |
| Weighted average by Cap. | +0.97% | +2.95% | +3.14% | +13.40% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 4.03B 3.45B 3.23B 2.95B 5.56B 386B 5.62B 38.13B 14.86B 194B 15.13B 14.8B 640B | 4.1B 3.51B 3.29B 3.01B 5.66B 392B 5.72B 38.79B 15.12B 197B 15.4B 15.06B 652B |
| Net income | 790M 676M 633M 579M 1.09B 75.54B 1.1B 7.47B 2.91B 37.93B 2.96B 2.9B 125B | 566M 484M 453M 415M 780M 54.13B 789M 5.35B 2.09B 27.18B 2.12B 2.08B 89.88B |
| Net Debt | 321M 275M 257M 236M 443M 30.74B 448M 3.04B 1.18B 15.44B 1.21B 1.18B 51.05B | 421M 360M 337M 309M 581M 40.27B 587M 3.98B 1.55B 20.22B 1.58B 1.55B 66.87B |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
- Stock Market
- Stocks
- HOLX Stock
Select your edition
All financial news and data tailored to specific country editions
